NGNE
Neurogene Inc
31.30$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | 100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 351.0% | – | |
| – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | -251.0% | – | |
| – | – | – | – | – | – | – | 131.2% | – | – | – | – | – | 6,585.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 2,444.6% | – | |
| – | – | – | – | – | – | – | 194.1% | – | – | – | – | – | 8,679.2% | – | |
| – | – | – | – | – | – | – | -94.1% | – | – | – | – | – | -8,930.3% | – | |
| – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | 1.3% | – | |
| – | – | – | – | – | – | – | -126.3% | – | – | – | – | – | -8,123.7% | – | |
| – | – | – | – | – | – | – | -126.3% | – | – | – | – | – | -8,123.7% | – | |
| – | – | – | – | – | – | – | -126.3% | – | – | – | – | – | -7,771.4% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.